Elevated LILRB1 expression predicts poor prognosis and is associated with tumor immune infiltration in patients with glioma
Abstract Background Leukocyte immunoglobulin-like receptor subfamily B1 (LILRB1) is regarded as an inhibitory molecule. However, the importance of LILRB1 expression in glioma has not yet been determined. This investigation examined the immunological signature, clinicopathological importance and prog...
Main Authors: | Renheng Zou, Xunlong Zhong, Kairong Liang, Cheng Zhi, Danmin Chen, Zhichao Xu, Jingbai Zhang, Degui Liao, Miaoling Lai, Yuhao Weng, Huaidong Peng, Xiao Pang, Yunxiang Ji, Yanbin Ke, Hongri Zhang, Zhaotao Wang, Yezhong Wang |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-05-01
|
Series: | BMC Cancer |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12885-023-10906-2 |
Similar Items
-
LILRB4 Checkpoint for Immunotherapy: Structure, Mechanism and Disease Targets
by: Zhiqing Xiang, et al.
Published: (2024-02-01) -
Molecular regulatory mechanism of LILRB4 in the immune response
by: Haiyin Liu, et al.
Published: (2023-02-01) -
Placental Malaria is Associated with Higher LILRB2 Expression in Monocyte Subsets and Lower Anti-Malarial IgG Antibodies During Infancy
by: Celia Dechavanne, et al.
Published: (2022-07-01) -
Pan-cancer analysis reveals distinct clinical, genomic, and immunological features of the LILRB immune checkpoint family in acute myeloid leukemia
by: Zi-jun Xu, et al.
Published: (2022-09-01) -
Prognostic impact of LILRB4 expression on tumor‐infiltrating cells in resected non‐small cell lung cancer
by: Sakiko Kumata, et al.
Published: (2023-07-01)